Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours

By J. Rodón, G. Argilés, R. Connolly, U. Vaishampayan, M. D. de Jonge, E. Garralda, M. Giannakis, David C. Smith, J. Dobson, M. Mclaughlin and 5 more. 2021

132 citations recorded by the source corpus.

Subfields: Cell Biology, Immunology, Molecular Biology